Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.
Guangyao LiMatthew J CrowleyHuilin TangJeff Y YangRobert S SandlerTiansheng WangPublished in: Diabetes care (2019)
Keyphrases